NewsFDASaturday, October 25, 2025 · October 25, 2025
Hemlibra Expanded Indication Approved for All Hemophilia A
WHY IT MATTERS
Broadens access to the most widely used hemophilia A prophylaxis.
FDA approved expanded indication for Hemlibra covering all severity levels regardless of inhibitor status.
Related conditions
Related news
FDA
FDA Approves XTORO
XTORO (FINAFLOXACIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…
FDA
FDA Approves SABRIL
SABRIL (VIGABATRIN) received FDA approval.…
FDA
FDA Approves IOPIDINE
IOPIDINE (APRACLONIDINE HYDROCHLORIDE) received FDA approval.…